Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/29722
Título : Comparison of Hybribio-H13 and Hybrid Capture 2 Human Papillomavirus tests for detection of CIN2+ and CIN3+
Autor : Agudelo Fernández, María Cecilia
Torres González, Edmundo
Agudelo, Samuel
Ramírez Pineda, Arianis Tatiana
Castañeda Vanegas, Kelly Melisa
Kinslow, Connor J.
Rodríguez Herrera, María
Garland, Lisa
Xie, Yi
Orozco Castaño, Carlos Alberto
Stoler, Mark
Dean, Michael
Sánchez Vásquez, Gloria
metadata.dc.subject.*: Neoplasias del Cuello Uterino
Uterine Cervical Neoplasms
Papillomaviridae
Hybribio, H13
Human Papillomavirus
high-risk HPV testing
Test validation
Fecha de publicación : 2022
Resumen : RESUMEN: This study was carried out to compare the performance of the low-cost H13 test with HC2 to detect CIN2+ and CIN3+. Archived baseline samples tested by HC2 from women with biopsy-colposcopy directed diagnosis of CIN2+ (n=143) and CIN3+ (n=51) and 632 women with <CIN2, were retrospectively and blindly tested by H13. Relative sensitivity of H13 versus HC2 for detecting CIN2+ was 0.89 (90%CI,0.80-0.98; pni=0.66) and for CIN3+ was 0.92 (90%CI, 0.85-0.98; pni=0.35). Relative specificity was 1.19 (90% CI,1.05-1.33; pni<0.00001). In conclusion, H13 was as specific but less sensitive than HC2 for detecting CIN2+ or CIN3+.
Aparece en las colecciones: Otros Materiales en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
BDD_H13_28-06-2018_Infeccionycancer.xlsx
  Restricted Access
Datos81.4 kBMicrosoft Excel XMLVisualizar/Abrir  Request a copy
Request for Data Access.docxFormato de solicitud65.67 kBMicrosoft Word XMLVisualizar/Abrir


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.